samedan logo

 
 
spacer
home > ict > media info
MEDIA INFORMATION
   

WHY ADVERTISE?

ICT occupies a crucial position in pharmaceutical publishing, offering an advertising platform to contract product and service providers from across the clinical trials market. Its targeted circulation to
key global decision makers guarantees maximum exposure for
your company. Furthermore, ICT’s media partnerships with key industry events provide advertisers with bonus distribution opportunities throughout the year.

ICT’s presence online offers exciting digital opportunities. With
a comprehensive company directory, and press releases and
events listing facilities, the website is the ideal platform to
showcase banners and logos. The website is complemented
by the magazine’s ebook – an interactive digital edition of ICT
that opens up a whole host of rich media advertising options.

     

READERSHIP: JOB FUNCTIONS

Business Development 
Clinical Research
Corporate Management/CEO
Drug Safety
Industry Consultancy
IT/Data Management
Laboratory
Management

 

Marketing and Sales
Preclinical/Clinical Trial/Clinical Supply 
Product Development
Project Management
Purchasing/Supplies
QA/QC
R&D


 
 



   

ADVERTISING RATES

 

WEB SITE FACILITIES

SIZE
RATE
FRONT COVER LOGO 
 £1,500
DOUBLE PAGE SPREAD
£4,550
SINGLE PAGE
£2,850
HALF PAGE
£1,575
QUARTER PAGE
£895
OPPOSITE CONTENT PAGES
£3,750
OPPOSITE EDITOR’S LETTER
£3,750
INSIDE FRONT COVER
£5,950
INSIDE BACK COVER
£3,450
OUTSIDE BACK COVER
£6,750

 

1) Hyperlink from a relevant section of our website to client website
2) Banner and/or logo on
our website (see below for
banner specifications)
3) Client news page – to use for press releases during the duration
of advertising.
4) Corporate profile up to 350 words

Banner Specifications 
GIF or JPEG (if static) or SWF (flash), 468x60 or 200x150 pixels.

     

REPROGRAPHIC MECHANICAL SPECIFICATIONS

MECHANICAL DETAILS (IN MM)

Type Size
Trim Size
Bleed Size

Double Page*

273 x 396
297 x 420
303 x 426

One Page

273 x 186
297 x 210
303 x 213

1/2 page (horizontal)

135 x 186
148 x 210
151 x 213

1/2 page (vertical)

273 x 92
297 x 105
303 x 108

1/4 page

135 x 92
N/A
N/A


Electronic pictures or graphics can be supplied in the following formats:

1. Adobe Photoshop CS2 TIFF (*.tif), JPEG, PSD or EPS
2. Adobe Illustrator CS2 EPS

Electronic images/graphics must be supplied at high resolution (at least 300dpi)
Electronic images/graphics should be in CMYK colour.
Please do not send picture files embedded in Microsoft
Word documents.
Please supply them as separate attachments.

Pictures can be supplied as good quality colour or black and
white photographs

Client designed adverts should be supplied in one of the following ways:

1. QuarkXpress 6 (not Quark Passport) - Relevant high-resolution graphics and fonts must also be supplied.

2. Adobe Illustrator CS2 - Images and graphics must be
embedded. Fonts should be supplied if they are not embedded/converted to outline.

3. Adobe Acrobat PDF - Advert PDFs must be supplied optimised
for high-quality printing. All colours (including pictures) must be
CMYK, and not RGB or Pantone. Graphics must be high-resolution (300dpi), with all fonts embedded. Bleed adverts must include registration markings and bleed. We are unable to make ammendments to PDF files.

All adverts should be supplied with a colour copy of the advert.
PDFs are supplied entirely at the client’s own risk and the publisher accepts no responsibility for any errors in printing. Electronic files
can be emailed to us. Larger files (above 10Mb) should be supplied to us on CD.

spacer


Published quarterly in
February, May,
August, and November
 
Industry Events

2020 Avoca Quality and Innovation Summit

3-4 June 2020, Amsterdam, The Netherlands

The 2020 Avoca Quality and Innovation Summit will take place 3-4 June 2020, in Amsterdam, The Netherlands.
More info >>

 
News and Press Releases

WuXi STA and Dizal Pharmaceutical Sign CMC Development and Manufacturing Agreement

STA Pharmaceutical Co., Ltd., (WuXi STA) – a subsidiary of WuXi AppTec – and Dizal Pharmaceutical, a biotechnology company, announce a strategic partnership. Under the terms of the collaboration, WuXi STA will become the preferred CDMO partner of Dizal Pharmaceutical for GMP production, providing integrated CMC (Chemical, manufacturing and Control) process research and manufacturing services from API to drug product.
More info >>

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement